Expression of Concern
No Authors listed
The Editor in Chief and the Publisher are issuing an expression of concern to alert readers to the fact that the following articles are under investigation due to concerns raised regarding non-verifiable nucleotide sequences and cell lines used in the following articles:
– Shi YX, Ye BL, Hu BR, Ruan XJ. Expression of miR-1294 is downregulated and predicts a poor prognosis in gastric cancer. Eur Rev Med Pharmacol Sci 2018; 22 (17): 5525-5530–DOI: 10.26355/eurrev_201809_15813–PMID: 30229824.
– Dong SR, Ju XL, Yang WZ. STAT5A reprograms fatty acid metabolism and promotes tumorigenesis of gastric cancer cells. Eur Rev Med Pharmacol Sci 2019; 23 (19): 8360-8370–DOI: 10.26355/eurrev_201910_19147–PMID: 31646566.
– Chen J, Yuan ZH, Hou XH, Shi MH, Jiang R. LINC01116 promotes the proliferation and inhibits the apoptosis of gastric cancer cells. Eur Rev Med Pharmacol Sci 2020; 24 (4): 1807-1814–DOI: 10.26355/eurrev_202002_20358–PMID: 32141549.
Further updates will be provided once the investigation is completed.
The authors have been notified about this expression of concern.
Free PDF Download
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
No Authors listed
Expression of Concern
Eur Rev Med Pharmacol Sci
Year: 2024
Vol. 28 - N. 10
Pages: 3473-3473
DOI: 10.26355/eurrev_202405_36273